Hyperbilirubinemia in the 2000s: What Should We Do Next?

Gail Ross

doi:10.1055/s-2003-45385

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2003; 20(8): 415-424
DOI: 10.1055/s-2003-45385

REVIEW ARTICLE

Hyperbilirubinemia in the 2000s: What Should We Do Next?

Gail Ross

Department of Pediatrics, Weill Medical College of Cornell University, New York, New York

Abstract

ABSTRACT

Changes in healthcare policy mandating early discharge of healthy, full-term infants and the higher prevalence of breast-feeding of newborns have contributed to an increased number of term infants being readmitted to the hospital for hyperbilirubinemia. At high levels, total serum bilirubin causes kernicterus, which is associated with severe neurological sequelae. This article provides a review of prior studies that have examined whether and at what levels total serum bilirubin affects neurodevelopmental outcome in term infants. In addition, the article reviews some approaches in the literature that suggest means of preventing high levels of hyperbilirubinemia in term infants.

KEYWORDS

Hyperbilirubinemia - kernicterus - total serum bilirubin - neurodevelopmental outcome

Volltext

Referenzen

REFERENCES

1 Davidson L T, Merritt K K, Weech A A. Hyperbilirubinemia in the newborn. Am J Dis Child . 1941; 61 958-980
2 Maisels M J, Gifford K, Antle C E. et al . Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics . 1986; 78 837-843
3 Palmer C, Mujsce D J. Common neonatal illnesses. In: Hoekelman RA, ed. Primary Pediatric Care St. Louis: Mosby; 2001: 587-599
4 Harris M C, Bernbaum J C, Polin J R. et al . Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics . 2001; 107 1075-1080
5 Newman T B, Escobar G J, Gonzales V. et al . Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics . 1999; 104 1198-1203
6 Bhutani V K, Johnson L H, Sivieri E M. Risk assessment of hyperbilirubinemia in near-term newborns. Pediatrics . 1999; 104 (suppl 3) 741
7 Volpe J J. Bilirubin and brain injury. Neurology and the Newborn. 4th ed. Philadelphia: WB Saunders; 2001: 521-546
8 Bratlid D, Cashore W J, Oh W. Effect of serum hyperosmalality on opening of blood-brain barrier for bilirubin in rat brain. Pediatrics . 1983; 71 909-912
9 Ives N K, Cox D WG, Gardiner R M. et al . The effects of bilirubin on brain energy metabolism during normoxia and hypoxia: an in vitro study using nuclear magnetic resonance spectroscopy. Pediatr Res . 1988; 23 569-573
10 Dennery P A, Seidman D S, Stevenson D K. Neonatal hyperbilirubinemia. N Engl J Med . 2001; 344 581-590
11 Wennberg R P. Brilirubin recommendations present problems: new guidelines simplistic and untested. Pediatrics . 1992; 89 821-822
12 Killander A, Michaelsson M, Muller-Eberhand U. et al . Hyperbilirubinemia in full-term newborn infants: a follow-up study. Acta Paediatr Scand . 1963; 52 481-484
13 Johnson L, Brown A K. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics . 1999; 104 (suppl 3) 736
14 Gartner L M, Snyder R N, Chabon R S. et al . Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics . 1970; 45 906-917
15 Lee K-S, Gartner L M, Eidelman A I, Ezhuthachan S. Unconjugated hyperbilirubinemia in very low birth weight infants. Clin Perinatol . 1977; 4 305-320
16 Lucey J F. The unsolved problem of kernicterus in the susceptible low birth weight infant. Pediatrics . 1972; 49 646-651
17 Osborn L M, Lenarsky C, Oakes R C. et al . Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics . 1984; 74 371-374
18 Newman T B, Maisels M J. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics . 1992; 89 809-818
19 Watchko J F, Oski F A. Bilirubin 20 mg/dL: vingintiphobia. Pediatrics . 1983; 71 660-663
20 Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics. Practice Parameter: management of hyperbilirubinemia in the healthy term infant. Pediatrics . 1994; 94 558-561
21 Valaes T. Bilirubin toxicity: the problem was solved a generation ago. Pediatrics . 1992; 89 819-821
22 Maisels M J, Newman T B. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics . 1995; 96 730-733
23 Liu L L, Clemens C J, Shay D K. et al . The safety of newborn early discharge: the Washington State experience. JAMA . 1997; 278 293-298
24 Johnson L, Bhutani V K. Guidelines for management of the jaundiced term and near-term infant. Current Controversies in Perinatal Care III. Clin Perinatol . 1998; 25 555-573
25 Bhutani V K, Johnson L, Sivieri E M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics . 1999; 103 6-14
26 American Academy of Pediatrics Subcommittee on Neonatal Hyperbilirubinemia. Jaundice and kernicterus. Pediatrics . 2001; 108 763-765
27 Johnson L, Bhutani V K. Reply to the Editor. J Pediatr . 2003; 142 214-215
28 Braveman P, Egerter S, Pearl M, Marchi K, Miller C. Early discharge of newborns and mothers: a critical review of the literature. Pediatrics . 1995; 96 716-726
29 Braveman P, Kessel W, Egerter S, Richmond J. Early discharge and evidence-based practice: good science and good judgement. JAMA . 1997; 278 334-336
30 Britton J R, Britton H L, Beebe S A. Early discharge of the term newborn: a continued dilemma. Pediatrics . 1994; 94 291-295
31 Poland R L. Preventing kernicterus: almost there. J Pediatr . 2002; 140 385-386
32 Hsia D Y, Allen Jr H F, Gellis S S, Diamond L K. Erytheroblastosis fetalis VII: studies of serum bilirubin in relation to kernicterus. N Engl J Med . 1952; 247 668-671
33 Temple C. Developmental Cognitive Neuropsychology. East Sussex, UK: Psychology Press; 1997
34 Kolb B, Whishaw I Q. Fundamentals of Human Neuropsychology 4th ed. New York: WH Freeman; 1998
35 Newman T B, Maisels M J. Does hyperbilirubinemia damage the brain of full-term infants?. Clin Perinatol . 1990; 17 331-338
36 Niswander K, Gordon M. The Women and Their Pregnancies. Philadelphia: WB Saunders; 1972
37 Boggs T, Hardy J, Frazier T. Correlation of neonatal serum total bilirubin concentration and developmental status at age eight months: preliminary report from the collaborative project. J Pediatr . 1967; 71 553-560
38 Scheidt P C, Mellits E D, Hardy J B. et al . Toxicity to bilirubin in neonates: infant development during the first year in relation to maximum neonatal serum bilirubin concentration. J Pediatr . 1977; 91 292-297
39 Hardy J B, Peeples M O. Serum bilirubin levels in newborn infants: distributions and associations with neurological abnormalities during the first year of life. Johns Hopkins Med J . 1971; 128 265-272
40 Naeye R L. Amniotic fluid infections, neonatal hyperbilirubinemia, and psychomotor impairment. Pediatrics . 1978; 62 497-503
41 Rubin R A, Balow B, Fisch R O. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr . 1979; 94 601-604
42 Nelson K B, Ellenberg J H. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med . 1986; 315 81-86
43 Bjure J, Liden G, Reinand F, Vestby A. A follow-up study of hyperbilirubinaemia in full-term infants without iso-immunization. Acta Paediatr Scand . 1961; 50 437-443
44 Culley P, Powell J, Waterhouse J. et al . Sequelae of neonatal jaundice. BMJ . 1970; 3 383-386
45 Rosta Z M, Bekefi D, Popper P. et al . Neonatal pathological jaundice: seven to nine years follow up. Acta Paediatr Acad Sci Hung . 1971; 12 317-321
46 Seidman D S, Paz I, Stevenson D K. et al . Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics . 1991; 88 828-833
47 Fohl E, Lombos O. The prognosis of neonatal hemolysis due to A-B-O imcompatibility, without exchange transfusion. Ann Paediatr . 1964; 203 279-287
48 Holmes G E, Miller J B, Smith E E. Neonatal bilirubinemia in production of long-term neurological deficits. Am J Dis Child . 1969; 117 395-405
49 Bengtsson B, Verneholt J. A follow-up study of hyperbilirubinemia in healthy full-term infants without isoimmunization. Acta Paediatr Scand . 1961; 50 437-443
50 Newman T N, Klebanoff M A. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics . 1993; 92 651-657
51 Vohr R B, Kapr D, O'Dea C. et al . Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. J Pediatr . 1990; 117 288-291
52 Gurses D, Kilic I, Sahiner T. Effects of hyperbilirubinemia on cerebrocortical electrical activity in newborns. Pediatr Res . 2002; 52 125-130
53 Paludetto R, Mansi G, Raidmondi F. et al . Moderate hyperbilirubinemia induces a transient alteration of neonatal behavior. Pediatrics . 2002; 110 E50
54 Gupta A K, Mann S B. Is auditory brainstem response a bilirubin toxicity marker?. Am J Otolaryngol . 1998; 19 232-236
55 Agarwal R, Kaushal M, Agarwal R, Paul V K, Deorari A K. Early neonatal hyperbilirubinemia using first-day serum bilirubin level. Indian Pediatr . 2002; 39 724-730
56 Grimmer I, Berger-Jones K, Buhrer C. et al . Later neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr . 1999; 88 661-663
57 Soorani-Lunsing I, Woltil H A, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr Res . 2001; 50 701-705
58 Hadders-Algra M, Huisjes H J, Touwen B CL. Perinatal risk factors and minor neurological dysfunction: significance for behaviour and school achievement at nine years. Dev Med Child Neurol . 1988; 30 482-491
59 Gillberg I C, Gillberg C. Children with preschool minor neurodevelopmental disorders. IV: behavior and school achievement at age 13. Dev Med Child Neurol . 1989; 31 3-13
60 Hadders-Algra M, Groothius A MC. Quality of general movements in infancy is related to neurological dysfunction, ADHD, and aggressive behaviour. Dev Med Child Neurol . 1999; 41 381-391
61 Alpay F, Sarici S U, Tosuncuk H D, Serdar M A, Inanc N, Gokcay E. The value of first-day billirubin measurement in predicting the development of significant hyperbilirubinemia. Pediatrics . 2000; 106 E16
62 Tayaba R, Gribetz D, Gribetz I, Holzman I R. Noninvasive estimation of serum bilirubin. Pediatrics . 1998; 102 E28
63 Moyer V A, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med . 2000; 154 391-394
64 Bhutani V K, Gourley G R, Adler S, Kreamer B L, Dalin C, Johnson L H. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics . 2000; 106 E17
65 Vreman H J, Verter J, Oh W. et al . Interlaboratory variability of bilirubin measurements. Clin Chem . 1996; 42 869-873
66 Odell G B, Storey G NB, Rosenberg L A. Studies in kernicterus, III: the saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr . 1970; 76 12-2
67 Johnson L, Boggs R R. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview Washington DC: National Academy of Sciences 1974: 122-149
68 Dai J, Parry D M, Krahn J. Transcutaneous bilirubinometry: its role in the assessment of neonatal jaundice. Clin Biochem . 1997; 30 1-9
69 Hansen T W. Kernicterus: an international perspective. Semin Neonatol . 2002; 7 103-109
70 Maisels M J, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics . 1997; 99 599-601
71 Dennery P A, Rhine W D, Stevenson D K. Neonatal jaundice: what now?. Clin Pediatr (Phila) . 1995; 34 103-107
72 Stevenson D K, Vreman H J, Oh W. et al . Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem . 1994; 40 1934-1939
73 Stevenson D K, Fanaroff A A, Maisels M J. et al . Prediction of hyperbilirubinemia in near-term and term infants. J Perinatol . 2001; 21 (suppl 1) S63-S72
74 Newman T B, Xiong B, Gonzales V M. et al . Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med . 2000; 154 1140-1147
75 Seidman D S, Stevenson D K, Ergaz A. et al . Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics . 1995; 96 727-729
76 Brown A K, Damus K, Kim M H. et al . Factors relating to readmission of term and near-term neonates in the first two weeks of life. J Perinat Med . 1999; 27 263-275
77 Gartner L. Management of jaundice in the well baby. Pediatrics . 1992; 89 826-827
78 Gourley G R. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol . 2002; 7 135-141
79 Madlon-Kay D J. Maternal assessment of neonatal jaundice after hospital discharge. J Fam Pract . 2002; 51 445-448
80 Conrad P D, Wilkering R B, Rosenberg A A. Safety of newborn discharge in less than 36 hours in an indigent population. Am J Dis Child . 1989; 143 98-101
81 Johnson L, Bhutani V K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr . 2002; 140 396-403